Partnering to Unlock the Full Potential of Ambrisentan

Noorik is a company focussed on research and development. As such, we are currently looking for Partners to co-develop micro-dose Ambrisentan, complete the technical and clinical development and make this project a commercial success.

If you would like to start a conversation and find out more about our project, results and vision, please contact us.